These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32967239)

  • 61. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation.
    Park JH; Lee NK; Lee SY
    Mol Cells; 2017 Oct; 40(10):706-713. PubMed ID: 29047262
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.
    Deepak V; Kruger MC; Joubert A; Coetzee M
    Biofactors; 2015; 41(6):403-13. PubMed ID: 26627060
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-κB and MAPK pathways.
    Zhou C; Liu W; He W; Wang H; Chen Q; Song H
    Int Immunopharmacol; 2015 Mar; 25(1):49-54. PubMed ID: 25617149
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CaMKII(δ) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway.
    Lu DZ; Dong W; Feng XJ; Chen H; Liu JJ; Wang H; Zang LY; Qi MC
    Mol Cell Endocrinol; 2020 May; 508():110791. PubMed ID: 32173349
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
    O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
    Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
    Baek JM; Ahn SJ; Cheon YH; Lee MS; Oh J; Kim JY
    Mol Med Rep; 2017 Feb; 15(2):784-792. PubMed ID: 28035412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gold Clusters Prevent Inflammation-Induced Bone Erosion through Inhibiting the Activation of NF-κB Pathway.
    Yuan Q; Gao F; Yao Y; Cai P; Zhang X; Yuan J; Hou K; Gao L; Ren X; Gao X
    Theranostics; 2019; 9(7):1825-1836. PubMed ID: 31037141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
    Zhao D; Shi Z; Warriner AH; Qiao P; Hong H; Wang Y; Feng X
    PLoS One; 2014; 9(7):e102706. PubMed ID: 25032991
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.
    Kim HJ; Yoon HJ; Kim SY; Yoon YR
    Mol Cells; 2014 Aug; 37(8):598-604. PubMed ID: 25134536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis.
    Izawa T; Mori H; Shinohara T; Mino-Oka A; Hutami IR; Iwasa A; Tanaka E
    PLoS One; 2016; 11(4):e0154107. PubMed ID: 27123995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts.
    Kim JH; Youn BU; Kim K; Moon JB; Lee J; Nam KI; Park YW; O'Leary DD; Kim KK; Kim N
    Cell Death Differ; 2014 Oct; 21(10):1613-21. PubMed ID: 24902903
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
    Matsumoto M; Sudo T; Saito T; Osada H; Tsujimoto M
    J Biol Chem; 2000 Oct; 275(40):31155-61. PubMed ID: 10859303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
    Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
    J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.